Tout sur les médicaments הכל על תרופות كل شيئ عن الأدوية Все о наркотиках 关于药品的一切 డ్రగ్స్ గురించి అన్ని 마약에 관한 모든 것 Όλα για τα Ναρκωτικά Complete Tracking of Drugs Across the World by Dr Anthony Melvin Crasto, Worldpeacepeaker, worlddrugtracker, PH.D (ICT), MUMBAI, INDIA, Worlddrugtracker, Helping millions, 9 million hits on google on all websites, 2.5 lakh connections on all networks, “ALL FOR DRUGS” CATERS TO EDUCATION GLOBALLY, No commercial exploits are done or advertisements added by me. This is a compilation for educational purposes only. P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent

The crystal structure and optical properties of a pharmaceutical co-crystal – the case of the melamine–barbital addition compound

Uncategorized

Jun 162014

Graphical abstract: The crystal structure and optical properties of a pharmaceutical co-crystal – the case of the melamine–barbital addition compound

The crystal structure and optical properties of a pharmaceutical co-crystal – the case of the melamine–barbital addition compound

M. Gryl, T. Seidler, K. Stadnicka, I. Matulková, I. Němec, N. Tesařová and P. Němec

CrystEngComm, 2014, 16, 5765 DOI:10.1039/C4CE00178H

The melamine barbital co-crystal is a product of crystal engineering of non-linear optical materials composed of pharmaceutically active ingredients. The resulting crystal phase shows a non-linear effect higher than that of KDP. The material was characterized by means of X-ray diffraction and optical property measurements and calculations.

http://pubs.rsc.org/en/Content/ArticleLanding/2014/CE/C4CE00178H?utm_medium=email&utm_campaign=pub-CE-vol-16-issue-26&utm_source=toc-alert#!divAbstract

The crystal structure and optical properties of a pharmaceutical co-crystal – the case of the melamine–barbital addition compound

M. Gryl,*^a T. Seidler,^a K. Stadnicka,^a I. Matulková,^b I. Němec,^b N. Tesařová^c and P. Němec^c

*Corresponding authors

^aDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland

E-mail: gryl@chemia.uj.edu.pl

^bDepartment of Inorganic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030, 128 40 Prague 2, Czech Republic

^cDepartment of Chemical Physics and Optics, Faculty of Mathematics and Physics, Charles University in Prague, Ke Karlovu 3, 121 16 Prague 2, Czech Republic

CrystEngComm, 2014,16, 5765-5768

DOI: 10.1039/C4CE00178H